Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 5, pp 896–905 | Cite as

The organizational framework of community pharmacies in Europe

  • Sílvia Filipa Martins
  • J. W. Foppe van Mil
  • Filipa Alves da CostaEmail author
Research Article

Abstract

Background The role of the pharmacist has undergone profound changes over the recent years. In most European countries, the tendency seems to be that pharmacists are moving from being product-oriented to service-oriented. An interesting series of papers describing care related services of pharmacy in various countries has been published in 2006, but much has changed since then. This paper aims to provide an updated view on the overall health care sector in Europe, with a special focus on services in community pharmacy. Objective To list and compare health care and community pharmacy structure in Europe; and to discuss the facilitators and barriers that can be found in health care systems and may promote or hinder the implementation of new community pharmacy services. Setting European community pharmacy practice. Methods A cross-sectional study was undertaken where data were collected using an online survey sent to a purposive sample of representatives from 27 European countries. Main outcome measure variation in professional community pharmacy services across Europe. Results Data were obtained from 22 respondents in 19 countries (70.4 %). Health care is mainly provided by a form of public National Health Services in 17 of the 19 countries. Demographic criteria for founding new pharmacies were present in 17 countries. Medicines are exclusively available in pharmacies in approximately one third of the countries. Smoking cessation (93.8 %), drug waste management (81.3 %) and pharmaceutical care programmes for specific diseases (77.8 %) were reported as the most widely disseminated services in European pharmacies. Conclusions There are still major differences between community pharmacy practice in Europe. Differences are mostly due to the legal framework and remuneration issues, which impact on the range of services available from pharmacies to the community of each country.

Keywords

Community pharmacy Community pharmacy services Health care services Europe 

Notes

Acknowledgments

The authors would like to thank respondents to the survey by providing data on their country and by their availability to check data originating and constant availability to clarify authors. We specially thank Pharmaceutical Care Network Europe for providing the initial platform that resulted in this study.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflicts of interest

The Authors declare that there is no conflict of interests.

References

  1. 1.
    World Health Organisation. Health systems service delivery. In ‘Health Systems’. http://www.who.int/healthsystems/topics/delivery/en/.
  2. 2.
    Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19:127–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Goodman RA, Bunnell R, Posner SF. What is “Community Health”? Examining the meaning of an evolving field in public health. Prev Med. 2014;67:28–61.CrossRefGoogle Scholar
  4. 4.
    van Mil JWF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harv Health Policy Rev. 2006;7(1):155–68.Google Scholar
  5. 5.
    Vogler S, Arts D, Sandberger K. Impact of pharmacy deregulation and regulation in European countries. Summary Report. Vienna, 2012. Gesundheit Österreich, Vienna.Google Scholar
  6. 6.
    Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006;40:512–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Deuning CM. Number of GPs with a pharmacy per municipality (Aantal apotheekhoudende huisartsen per gemeente 2014). In: Volksgezondheid Toekomst Verkenning, Nationale Atlas Volksgezondheid. Bilthoven: RIVM. http://www.zorgatlas.nl/zorg/eerstelijnszorg/farmaceutische-zorg/aantal-apotheekhoudende-huisartsen-per-gemeente-2009/.
  8. 8.
    Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother. 2005;39:1539–41.CrossRefPubMedGoogle Scholar
  9. 9.
    Gastelurrutia MA, Faus MJ, Fernández-Llimós F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39:2105–10.CrossRefPubMedGoogle Scholar
  10. 10.
    Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother. 2006;40:2228–34.CrossRefPubMedGoogle Scholar
  11. 11.
    Westerlund LOT, Björk T. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Van Mil JWF. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother. 2005;39:1720–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41:861–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Herborg H, Sorensen EW, Frokjaer B. Pharmaceutical care in community pharmacies: practice and research in Denmark. Ann Pharmacother. 2007;41(4):681–9.CrossRefPubMedGoogle Scholar
  15. 15.
    The Boston Consulting Group. Health Care System reform and short term savings opportunities, Iceland Health Care System project. http://www.velferdarraduneyti.is/media/ritogskyrslur2011/IIceland_HCS-Final_report-_Long_version.pdf.
  16. 16.
    Swedish Law on sales of medicinal products (SFS 2009:366).Google Scholar
  17. 17.
    Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications. Official Journal of the European Union. 2005.Google Scholar
  18. 18.
    Augusto GF. Cuts in Portugal’s NHS could compromise care. Lancet. 2012;379:400.CrossRefPubMedGoogle Scholar
  19. 19.
    Kanavos P, Schurer W, Vogler S. The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices. London/Vienna. 2011.Google Scholar
  20. 20.
    Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRefPubMedGoogle Scholar
  21. 21.
    Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, Cordina MA, Costa FA, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32(4):472–87.CrossRefPubMedGoogle Scholar
  22. 22.
    Chan P, Grindrod K, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy care services—clinical review. Can Pharm J. 2008;141(2):102–10.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  1. 1.Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM)Centro de Investigação Interdisciplinar Egas Moniz (CiiEM)CaparicaPortugal
  2. 2.Van Mil ConsultancyZuidlx arenNetherlands

Personalised recommendations